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Abstract. 
 
Pleckstrin homology (PH) domains are se-
 
quences of 
 
z
 
100 amino acids that form “modules” that 
have been proposed to facilitate protein/protein or pro-
tein/lipid interactions. Pleckstrin, first described as a 
substrate for protein kinase C in platelets and leuko-
cytes, is composed of two PH domains, one at each end 
of the molecule, flanking an intervening sequence of 
147 residues. Evidence is accumulating to support the 
hypothesis that PH domains are structural motifs that 
target molecules to membranes, perhaps through inter-
actions with G
 
bg
 
 or phosphatidylinositol 4,5-bisphos-
phate (PIP
 
2
 
), two putative PH domain ligands. In the 
present studies, we show that pleckstrin associates with 
membranes in human platelets. We further demon-
strate that, in transfected Cos-1 cells, pleckstrin associ-
ates with peripheral membrane ruffles and dorsal mem-
brane projections. This association depends on 
phosphorylation of pleckstrin and requires the pres-
ence of its NH
 
2
 
-terminal, but not its COOH-terminal, 
PH domain. Moreover, PH domains from other mole-
cules cannot effectively substitute for pleckstrin’s NH
 
2
 
-
terminal PH domain in directing membrane localiza-
tion. Lastly, we show that wild-type pleckstrin actually 
promotes the formation of membrane projections from 
the dorsal surface of transfected cells, and that this 
morphologic change is similarly PH domain dependent. 
Since we have shown previously that pleckstrin-medi-
ated inhibition of PIP
 
2
 
 metabolism by phospholipase C 
or phosphatidylinositol 3-kinase also requires pleck-
strin phosphorylation and an intact NH
 
2
 
-terminal PH 
domain, these results suggest that: (
 
a
 
) pleckstrin’s NH
 
2
 
-
terminal PH domain may regulate pleckstrin’s activity 
by targeting it to specific areas within the cell mem-
brane; and (
 
b
 
) pleckstrin may affect membrane struc-
ture, perhaps via interactions with PIP
 
2
 
 and/or other 
membrane-bound ligands.
 
S
 
ignal
 
 transduction pathways frequently use proteins
that contain discrete domains that can facilitate in-
termolecular interactions. Well-characterized exam-
ples of such protein “modules” include the Src homology 2
and phosphotyrosine binding domains, which target phos-
phorylated tyrosine residues (21, 40), and Src homology 3
domains, which bind polyproline sequences, (21, 36). Pleck-
strin homology (PH)
 
1
 
 domains, first described as 100–
amino acid sequences found at the amino and carboxyl
termini of the hematopoietic protein, pleckstrin, have
been proposed as a new class of functional domains. The
structures of PH domains from dynamin, spectrin, phos-
pholipase C 
 
d
 
1 (PLC
 
d
 
1), and the NH
 
2
 
 terminus of pleck-
strin have been determined and are virtually superimpos-
able, giving credence to their inclusion as a genuine family
of structural motifs, despite significant divergence in their
primary sequences (6–8, 11, 27, 37, 46). The molecular tar-
gets with which PH domains interact have not yet been
clearly elucidated. PH domains have been suggested to
bind to inositol phosphates (13), and the structures of ino-
sitol 1,4,5-trisphosphate complexed to the PH domains
from spectrin and PLC
 
d
 
1 have been recently reported (8,
18). The 
 
bg
 
 subunits from heterotrimeric G proteins (G
 
bg
 
)
have also been proposed as binding partners for PH do-
mains (28, 39, 42), and we, along with others, have shown
that PH domains from a number of different proteins can
interact with G
 
bg
 
 (4, 22, 33, 34, 38).
Pleckstrin is a 40-kD protein found solely in cells of he-
matopoietic origin and was first described as a major sub-
strate for protein kinase C in human platelets (15). When
expressed in Cos-1 cells, pleckstrin can inhibit phosphati-
dylinositol 4,5-bisphosphate (PIP
 
2
 
) hydrolysis initiated by
both G protein–coupled and growth factor receptors (1).
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1. 
 
Abbreviations used in this paper
 
: 
 
b
 
ARK, 
 
b
 
–adrenergic receptor kinase;
G
 
bg
 
, 
 
bg
 
 subunit of heterotrimeric GTP-binding proteins; HA, hemagglu-
tinin; PH, pleckstrin homology; PI3-K, phosphatidylinositol 3-kinase;
PIP
 
2
 
, phosphatidylinositol 4,5-bisphosphate; PLC, phospholipase C.
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This effect is dependent on the presence of an intact PH
domain at the amino terminus of pleckstrin and can be
regulated by phosphorylation of the molecule (2). Recom-
binant phospho-pleckstrin can also inhibit G
 
bg
 
-activated
phosphatidylinositol 3-kinase (PI3-K) activity in human
platelets (3). These data suggest a role for pleckstrin in the
inhibition of cellular pathways involving PIP
 
2
 
 and/or G
 
bg
 
.
More than 100 proteins have been reported to contain
PH domains. Among these are signaling molecules such as
Ras-GAP, Ras-GRF, Sos, 
 
b
 
-adrenergic receptor kinase
(
 
b
 
ARK), phospholipase C, insulin receptor substrates
(IRS-1 and 2), and structural molecules, including spectrin
and dynamin (12, 16, 29, 30, 35). Common to many of
these proteins is a functional requirement for membrane
localization, but there is a lack of traditional membrane-
anchoring groups such as lipophilic helices or sites for
posttranslational addition of lipid moieties. Several lines
of evidence support the hypothesis that PH domains serve
as membrane-targeting motifs. First, 
 
b
 
ARK must be lo-
cated near the cell membrane in order for it to become ac-
tivated and phosphorylate its receptor substrate. Deletion
of a region overlapping the PH domain of 
 
b
 
ARK dimin-
ishes its kinase activity, and replacing this sequence with
an isoprenylation site restores function to the molecule
(22, 33). Second, the transforming ability of the Lfc pro-
tein requires an intact PH domain, and an isoprenylation
site can effectively substitute for the PH domain in this ac-
tivity (45). Third, IRS-1 mutants truncated of their PH do-
mains are less effective substrates of the transmembrane
insulin receptor than is the wild-type IRS-1 molecule (31).
Fourth, a point mutation found within the PH domain of
Bruton’s tyrosine kinase activates the enzyme and also
causes increased membrane association (25). Fifth, the PH
domain at the carboxy terminus of 
 
b
 
G
 
 spectrin has been
shown to interact with brain membranes and to target
plasma membranes in vivo (41, 43), and, lastly, PLC
 
d
 
1 was
demonstrated to require a PH domain for association with
the plasma membrane (32).
Expanding the hypothesis that PH domains direct mem-
brane targeting, we show in this report that pleckstrin
interacts with membranes in human platelets. We also
demonstrate that pleckstrin associates with peripheral mem-
brane ruffles and membrane projections at the dorsal sur-
face of transfected Cos-1 cells. The localization appears to
be regulated by pleckstrin’s sites of phosphorylation and
to require the presence of the native NH
 
2
 
-terminal PH do-
main, the same structural features that we have previously
shown to be necessary for pleckstrin’s inhibition of PIP
 
2
 
metabolism. Moreover, pleckstrin also appears to promote
the formation of membranous projections from the dorsal
surface of transfected cells, thus suggesting a new role for
pleckstrin in mediating morphologic changes at the cell
membrane.
 
Materials and Methods
 
Platelet Fractionation
 
Human platelets from normal volunteers were isolated by differential cen-
trifugation of whole blood anticoagulated with acidified citrate dextrose
(85 mM sodium citrate, 11 mM dextrose, 71 mM citric acid). Platelets were
washed in Hepes/Tyrode buffer (129 mM NaCl, 8.9 mM NaHCO
 
3
 
, 2.8 mM
KCl, 0.8 mM KH
 
2
 
PO
 
4
 
, 56 mM dextrose, 10 mM Hepes, pH 7.4, 0.8 mM MgCl
 
2
 
)
with 1 
 
m
 
M prostaglandin E
 
1
 
, resuspended in ice-cold 30 mM KCl, 5 mM
Pipes, pH 6.5, 5 mM MgCl
 
2
 
, 2 mM DTT, 2 mM PMSF, 2 mM vanadate,
0.2% aprotinin, and 1 
 
m
 
g/ml leupeptin, and then lysed by nitrogen cavita-
tion. The lysate was spun first at 500 
 
g
 
 for 15 min to remove intact cells.
The supernatant from this low speed spin was then spun at 100,000 
 
g
 
 for
60 min, and the high speed membrane pellet was separated from the su-
pernatant. The high speed pellet was then extracted with 1% Triton X-100
in 30 mM KCl, 5 mM Pipes, pH 6.5, 5 mM MgCl
 
2
 
, 2 mM DTT, 2 mM
PMSF, 2 mM vanadate, 0.2% aprotinin, and 1 
 
m
 
g/ml leupeptin, and then
spun again at 100,000 
 
g
 
 for 30 min. The Triton-soluble supernatant was
separated from the Triton-insoluble pellet. Protein concentrations in each
sample were determined using a bicinchoninic microassay kit (Pierce
Chemical Co., Rockford, IL), and 50 
 
m
 
g of protein from each sample was
run on SDS-PAGE gels and transferred to nitrocellulose membranes,
which were then probed with either rabbit anti–pleckstrin antisera or an
antibody to the well-described membrane-bound protein, G
 
q
 
a
 
 (44).
Lactate dehydrogenase activity assays, used to demonstrate that cyto-
plasmic contents were not trapped in the membrane fraction, were per-
formed as follows: 100 
 
m
 
g of protein, 0.17 mg of NADH, and 80 
 
m
 
g of
pyruvate (Sigma Chemical Co., St. Louis, MO) were simultaneously
added to a cuvette containing 1 ml of 20 mM Hepes, pH 7.0, and the ab-
sorbance at 342 Å was measured every 15 s.
 
Construction of Pleckstrin Expression Vectors
 
The generation of expression plasmids encoding full-length human pleck-
strin, the NH
 
2
 
-terminal PH deletion variant (
 
D
 
6-99), and pleckstrin vari-
ants containing mutations at Ser
 
113
 
, Thr
 
114
 
, and Ser
 
117
 
 has been described
previously (1, 2). A vector encoding a COOH-terminal PH domain dele-
tion variant (
 
D
 
246-345) with the hemagglutinin antigen epitope tag fused
to the carboxy terminus of the molecule was generated by PCR overlap
extension according to the technique of Ho et al. (17). The hemagglutinin
antigen epitope tag was fused to the carboxy terminus of wild-type pleck-
strin and the other pleckstrin variants using PCR mutagenesis. A variant
deleted of both PH domains was constructed using a unique Pst site found
within the region between the two PH domains. Chimeric variants of
pleckstrin with the NH
 
2
 
-terminal PH domain replaced by the PH domain
from either 
 
b
 
ARK or dynamin were generated by PCR overlap extension
(17). A variant of pleckstrin in which two lysine residues (K13 and K14)
were mutated to asparagines was constructed by PCR mutagenesis, using
the technique of Landt et al. (23). The DNA sequences of all clones were
confirmed and inserted into pCMV5.
 
Cell Culture and Transient Transfections
 
Cos-1 cells (American Type Cell Culture, Rockville, MD) were grown in
DME with 10% FBS (GIBCO BRL, Gaithersburg, MD) and 1% penicil-
lin-streptomycin (GIBCO BRL) under 5.5% CO
 
2
 
. Plasmid DNA copre-
cipitated with calcium phosphate was layered on Cos-1 cells for 24 h before
cells were shocked with 10% glycerol for 2 min. Cells were washed three
times with DME, trypsinized (GIBCO BRL), and then replated onto two-well
chamber slides (Nunc, Naperville, IL) in preparation for immunostaining.
 
Antibody Preparation
 
Rabbit polyclonal antiserum (No. 354) was raised against a recombinant
protein corresponding to pleckstrin residues Glu
 
104
 
-Asp
 
233
 
. Murine ascites
from hybridoma cells expressing the mAb 12CA5 against the hemaggluti-
nin antigen were purified on a protein A column (Affi-Gel; Bio Rad Lab-
oratories, Hercules, CA), concentrated to 1.57 mg/ml, and stored at 4
 
8
 
C.
The anti-G
 
q
 
a
 
 antiserum was kindly supplied by Dr. David Manning (De-
partment of Pharmacology, University of Pennsylvania, Philadelphia).
 
Indirect Immunofluorescence
 
48 h after transient transfection, slides were washed with PBS, and then
fixed with freshly prepared 4% paraformaldehyde, 100 mM Pipes, pH 6.8,
2 mM EGTA, 2 mM MgCl
 
2
 
 for 30 min. Three washes in 150 mM Tris HCl,
pH 7.4, were performed to quench free aldehyde groups, followed by 10-
min permeabilization with 0.2% Triton X-100 in PBS. Cells were blocked
with 10% normal goat serum (Biosource Intl., Camarillo, CA) in PBS for
30 min at room temperature. 12CA5 antibody, prepared as above, was di-
luted 1:100 in 10% normal goat serum in PBS and applied to cells for 1 h
at 37
 
8
 
C. Cells were washed in PBS, and then incubated at 37
 
8
 
C for 1 h in
affinity-purified, FITC-labeled goat F(Ab)
 
2
 
 anti–mouse antisera (Bio-
source Intl.) diluted 1:200 in 10% normal goat serum in PBS. Slides were 
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washed in PBS, and then mounted in Citifluor antifadant mounting mate-
rial (University of Kent, Canterbury, United Kingdom).
For fluorescent double labeling of the cell surface and intracellular
pleckstrin, living transfected cells on chamber slides were washed with
PBS at room temperature, cooled on ice for 3 min, and then externally la-
beled with TRITC-conjugated WGA (Sigma Chemical Co.). After wash-
ing in PBS, cells were fixed, permeabilized, and stained as before.
Two methods were used for image collection and analysis. Conven-
tional fluorescence microscopy was performed using a Microphot-SA
microscope and camera (Nikon Inc., Garden City, NJ). We also used the
resources of the University of Pennsylvania Cancer Center Confocal Mi-
croscopy Core Facility. Confocal images were acquired from a 4D Upright
microscope (TCS-Medical Products Co., Huntington Valley, PA) and pro-
cessed on an IBM OS9 workstation (IBM Instruments, Inc., Danbury,
CT), using Scanware software. Three-dimensional reconstruction was per-
formed using a 3D software package provided to the Confocal Core on
loan from Leica Inc. (Deerfield, IL). All light microscopic figures were
shot with a 
 
3
 
40 objective.
 
In Vivo Phosphorylation Studies
 
48 h after transient transfection, cells were incubated for 4 h in phosphate-
free DME, containing 0.25 mCi/ml of 
 
32
 
P
 
i
 
. Cells were lysed in Frackleton
buffer (10 mM Tris, pH 7.6, 50 mM NaCl, 30 mM sodium pyrophosphate,
50 mM NaF) with 1% Triton X-100, 1 mM PMSF, 0.1% aprotinin, and 25
 
m
 
g/ml leupeptin. After cell lysis, pleckstrin and pleckstrin variants were
immunoprecipitated with 12CA5 and run on a polyacrylamide gel. Counts
on the dried gel were quantified using a phosphor imager (Molecular Di-
agnostics, Sunnyvale, CA) to determine the degree of phosphorylation of
the different pleckstrin variants.
 
Results
 
Pleckstrin Associates with Membrane
in Human Platelets
 
Pleckstrin is a major constituent of human platelets, com-
prising 0.65% of all platelet protein (26). To determine the
subcellular localization of pleckstrin within human plate-
lets, platelet lysates were spun at 100,000 
 
g
 
 and separated
into particulate and supernatant fractions. Equivalent
amounts of protein were run on SDS-PAGE gels and im-
munoblotted with the anti-pleckstrin antisera. Though
pleckstrin has previously been reported as a cytosolic
platelet protein (19, 26), the anti-pleckstrin immunoblot
shown in Fig. 1 
 
A
 
 shows that pleckstrin can be detected in
both the membrane pellet and the cytosolic supernatant of
human platelets. When this pellet was extracted with 1%
Triton X-100, the pleckstrin was found predominantly in
the Triton-soluble fraction, consistent with membrane as-
sociation (Fig. 1 
 
B
 
).
To demonstrate that the supernatant fraction did not
contain membrane components, we performed immuno-
blotting with antisera to the membrane-associated protein,
G
 
q
 
a
 
 (44), and showed that this protein was not found in
the supernatant fraction (Fig. 1 
 
A
 
). Similarly, the absence
of lactate dehydrogenase activity in the pellet fraction ar-
gues that it was not contaminated with cytosolic compo-
nents (data not shown).
 
Pleckstrin Associates with Peripheral
Membrane Ruffles and Dorsal Membrane Projections 
in Transfected Cos-1 Cells
 
Having determined that pleckstrin associates with platelet
membranes, we next sought to identify the regions of
pleckstrin required for this interaction. To do this, we used
Figure 1. Localization of pleck-
strin to membranes. (a) Anti-
pleckstrin immunoblot of mem-
brane pellet (lane 1) and
cytosolic supernatant (lane 2)
fractions from nitrogen-cavi-
tated human platelets showing
that a fraction of cellular pleck-
strin is found in the membrane
pellet. (b) As a control, an iden-
tical immunoblot probed with
antisera against the a subunit if
G protein, Gq, showing that Gq-a
is found only in the membrane
pellet (lane 1) and not in the su-
pernatant fraction (lane 2).
These blots are from an experi-
ment representative of seven
performed to date. (c) Anti-
pleckstrin immunoblots of the
Triton-soluble (lane 1) and -insol-
uble (lane 2) fractions of the high speed pellet from A are shown.
Pleckstrin is found predominantly in the Triton-soluble fraction,
consistent with membrane localization.
Figure 2. Pleckstrin vari-
ants. Wild-type pleckstrin
and pleckstrin variants were
tagged with the hemaggluti-
nin epitope (HA) recognized
by the mAb 12CA5 (Boeh-
ringer Mannheim Biochemi-
cals, Indianapolis, IN). 
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indirect immunofluorescence to study the intracellular lo-
cation of hemagglutinin (HA) epitope-tagged wild-type
and variant pleckstrins expressed in transfected Cos-1
cells. Fig. 2 shows schematic representations of the differ-
ent pleckstrin variants used in this series of experiments.
The attachment of the HA tag has been shown to have no
effect on the ability of the pleckstrin variants to inhibit
PLC activity (Abrams, C., unpublished observation).
Expressed wild-type pleckstrin was found diffusely
throughout the cytoplasm but concentrated most intensely
around the plasma membrane, where it associated with ar-
eas of membrane folding or ruffles along the periphery of
the cell (Fig. 3 
 
a
 
). In general, cells expressing wild-type
pleckstrin were flatter and broader than mock-transfected
cells or untransfected cells. Notably, cells transfected with
wild-type pleckstrin also demonstrated membranous pro-
Figure 3. Effect of PH do-
main deletions on localiza-
tion of pleckstrin. Indirect
immunofluorescence was per-
formed on Cos-1 cells tran-
siently transfected with HA-
tagged pleckstrin variants, us-
ing the 12CA5 mAb against
the HA epitope. Wild-type
pleckstrin (a) and COOH-
terminal PH-deleted pleck-
strin (D246-345) (c) localize
to peripheral ruffles and pro-
jections from dorsal surface
of the cell. Double PH-deleted
pleckstrin (D6-99, D246-345)
(b) and NH2-terminal PH-
deleted pleckstrin (D6-99)
(d) are diffusely localized.
This suggests that the NH2-
terminal PH domain but not
the COOH-terminal PH do-
main is critical for pleck-
strin’s localization to mem-
brane structures. Bar, 50 mm.
Figure 4. Confocal microscopy with three-dimensional image reconstruction was performed to better demonstrate membrane structures
projecting from the dorsal surface of the cell. (a) Cells expressing wild-type pleckstrin exhibit bright staining within dorsal projections
and peripheral ruffles. (b) Cells expressing double PH-deleted pleckstrin (D6-99, D246-345) exhibit diffuse staining. These images show
that wild-type pleckstrin staining is not within intracytoplasmic structures, but rather within projections from the cell surface.Ma et al. Pleckstrin and Membranes 1075
jections from their dorsal surface, and pleckstrin was also
concentrated within these structures (Fig. 3 a). Confocal
microscopy with three-dimensional reconstruction of im-
ages confirmed that these regions of intense pleckstrin
staining were projections from the surface of the cell,
rather than intracytoplasmic inclusions (Fig. 4 a).
The NH2-terminal PH Domain Is Required for 
Membrane Localization
To determine whether pleckstrin was associating with
membranes via its PH domains, Cos-1 cells were trans-
fected with a variant of pleckstrin lacking both PH domains
(D6-99, D246-345). Cells expressing this variant demon-
strated a diffuse pattern of staining, consistent with loss of
membrane interaction (Fig. 3 b). Unlike cells transfected
with wild-type pleckstrin, cells expressing this variant were
not broad and flattened, and intracytoplasmic vacuoles
could be clearly seen. Moreover, no dorsal projections
could be demonstrated by either light or confocal micros-
copy (Figs. 3 b and 4 b). To ascertain if these pleckstrin-
induced changes were related to the level of protein ex-
pression, we varied the concentration of plasmid used for
transfections, and then analyzed cells expressing different
levels of protein. The relative concentration of expressed
protein was compared with anti-HA immunoblots of trans-
fected cell lysates. Both the wild-type protein and the PH
domain-truncation variant (D6-99, D246-345) migrated on
an SDS polyacrylamide gel at their predicted molecular
masses of 40 and 18 kD, respectively (data not shown).
Though lower levels of expression of wild-type pleckstrin
produced less peripheral staining and fewer dorsal projec-
tions, these structural features were still present, even
when the expression of the wild-type protein was lower
than that of the pleckstrin D6-99, D246-345 variant. Thus,
the complete absence of peripheral staining and dorsal
projections in cells expressing the pleckstrin variant miss-
ing its PH domains cannot be explained on the basis of lev-
els of expression.
To examine the relative contribution from each of pleck-
strin’s two PH domains to its membrane localization, pleck-
strin mutants individually deleted of either the NH2-termi-
nal PH domain (D6-99) or the COOH-terminal PH domain
(D246-345) were studied. Cells expressing the COOH-
terminal PH domain–deleted variant (D246-345) stained in
a pattern indistinguishable from that of the wild-type mol-
ecule, (Fig. 3 c). As predicted by their amino acid se-
quences, these expressed proteins both migrated at 29 kD
on SDS-PAGE as determined by immunoblotting with the
anti-HA tag antibody, 12CA5. The cells were flat and
showed peripheral staining and dorsal projections. In con-
trast, the NH2-terminal PH domain–deleted mutant (D6-
99) was diffusely localized and had neither peripheral
staining nor dorsal projections (Fig. 3 d). This suggests
that the NH2-terminal PH domain, and not the COOH-
terminal PH domain, is critical in targeting pleckstrin to
membranes and mediating morphologic changes.
Pleckstrin Must Be Phosphorylated to Associate
with Membranes
Pretreating Cos-1 cells with 50 nM PMA affected neither
the morphology of the cell nor the localization of ex-
pressed wild-type pleckstrin (data not shown). However,
we have previously determined that, when overexpressed
in Cos-1 cells, wild-type pleckstrin predominately exists in
the phosphorylated state (2). Thus, it is still possible that
phosphorylation regulates the ability of pleckstrin to asso-
ciate with peripheral membranes and induce morphologic
changes. To test this hypothesis, we analyzed two pleck-
strin variants in which Ser113, Thr114, and Ser117, the resi-
dues normally phosphorylated by protein kinase C (2),
were collectively mutated to either glutamates (3-phos
glu) or to glycines (3-phos gly). We have previously shown
that replacing the sites of phosphorylation with glutamate
residues mimics the state of phosphorylation by introduc-
Figure 5. Effect of pleckstrin phosphorylation on intracellular lo-
calization. Cos-1 cells were transfected with HA-tagged variants
of pleckstrin that had the residues normally phosphorylated by
protein kinase C (Ser113, Thr114, Ser117) mutated to either gluta-
mates (3-phos glu) or to glycines (3-phos gly). (a) The 3-phos glu
variant produced the same pattern of staining as did the wild-type
molecule, showing staining at the periphery and within dorsal
projections. This variant has previously been shown to be consti-
tutively active in mediating inhibition of PIP2 metabolism. (b)
The 3-phos gly mutant, which cannot be phosphorylated, is dif-
fusely localized and does not associate with membrane structures.
This suggests that pleckstrin phosphorylation is critical for its ef-
fective recruitment to membranes.The Journal of Cell Biology, Volume 136, 1997 1076
ing a cluster of negative charges in a region adjacent to the
NH2-terminal PH domain. This variant was previously
shown to be constitutively active in inhibiting PLC and
PI3-K activity (2, 3). When this constitutively active pleck-
strin variant was tested, it produced a phenotype and pat-
tern of staining identical to that of the wild-type molecule
(Figs. 3 a and 5 a).
The pleckstrin variant containing glycine substitutions
at the sites of phosphorylation (3-phos gly) is relatively in-
active biochemically when compared with the wild-type
protein. For example, this mutant is much less efficient
than wild-type pleckstrin at inhibiting PLC and PI3-K ac-
tivity (2, 3). Cells expressing the 3-phos gly variant stained
diffusely and were of the same size and shape as mock-
transfected cells (Fig. 5 b). Immunolocalization of this
variant in transfected Cos-1 cells produces a diffuse cyto-
plasmic pattern, similar to the variant truncated of its
NH2-terminal PH domain (pleckstrin D6-99). This suggests
that pleckstrin must be phosphorylated or contain charged
residues in place of the sites of phosphorylation in order
for it to bind to its target within the plasma membrane.
This result may contrast with the finding that a fraction of
cellular pleckstrin was associated with the cell membrane
in unstimulated platelets. However, at this point we can-
not exclude the possibility that these platelets were par-
tially activated during our preparative process, thus result-
ing in pleckstrin phosphorylation.
The requirement for pleckstrin to be phosphorylated to
associate with Cos-1 cell membranes could be explained
by two possible hypotheses: (a) the NH2-terminal PH do-
main, which is structurally regulated by pleckstrin phos-
phorylation, is critical for membrane association; or (b)
pleckstrin phosphorylation, which is regulated by the NH2-
terminal PH domain, is required for membrane localiza-
tion. To address this issue, we analyzed the state of phos-
phorylation of each of the expressed pleckstrin variants.
Transfected Cos-1 cells were labeled with 32Pi, and the pleck-
strin variants were immunoprecipitated and fractionated by
SDS-PAGE. The relative radioactivity of each variant was
compared by analysis on a phosphor imager. The wild-type
pleckstrin and the pleckstrin variants missing either the
NH2-terminal PH domain (D6-99) or the COOH-terminal
PH domain (D246-345) were radiolabeled in vivo approxi-
mately equally (Fig. 6 A). Anti-pleckstrin immunoblots
were performed in parallel to verify that each variant was
expressed and immunoprecipitated equivalently (Fig. 6 B).
Thus, it is the NH2-terminal PH domain of pleckstrin
that is critical for its association with the plasma mem-
brane. The phosphorylation of pleckstrin appears to regu-
late this PH domain but does not, by itself, appear to be
sufficient for membrane association.
Other PH Domains Cannot Substitute for Pleckstrin’s 
NH2-terminal PH Domain
Since the structures of PH domains from a number of dif-
ferent proteins are all remarkably similar, we determined
if different PH domains could mediate membrane localiza-
tion when substituted in place of pleckstrin’s NH2-terminal
PH domain. Plasmids directing the expression of chimeric
pleckstrin variants were constructed in which pleckstrin’s
NH2-terminal PH domain was replaced by the PH domain
from either bARK (NPH-bARK) or dynamin (NPH-dyna-
Figure 6. Effect of PH domain deletions on pleckstrin variant
phosphorylation. Cos-1 cells were transfected with either wild-
type pleckstrin or pleckstrin variants missing either the NH2-ter-
minal PH domain (D6-99) (lane 2) or the COOH-terminal PH do-
main (D246-345) (lane 3). 48 h after transient transfection, cells
were labeled with 32Pi, immunoprecipitated, and run on SDS-
PAGE gels. A shows that wild-type pleckstrin (lane 1) and the
pleckstrin variants missing either the NH2-terminal PH domain
(lane 2) or the COOH-terminal PH domain (lane 3) were phos-
phorylated equally. B shows an antipleckstrin immunoblot per-
formed in parallel, demonstrating that these variants all ex-
pressed and immunoprecipitated equally well.
Figure 7. Localization of pleckstrin NH2-terminal PH domain
chimeras. Cos-1 cells were transfected with HA-tagged variants
of pleckstrin in which the NH2-terminal PH domain had been re-
placed with either the PH domain of bARK (a) or dynamin (b).
Neither chimera behaved like wild-type pleckstrin, suggesting
that pleckstrin’s native NH2-terminal PH domain is making spe-
cific interactions with membrane-bound ligands in which other
PH domains, despite having striking structural similarities, can-
not effectively substitute.Ma et al. Pleckstrin and Membranes 1077
min). These two chimeras were expressed at their pre-
dicted molecular weight as judged by anti-HA immunoblots.
Neither chimera behaved like wild-type pleckstrin. Cells
expressing either of these molecules stained diffusely, had
no dorsal projections, and were of normal size and shape
(Fig. 7, a and b). This suggests that pleckstrin’s native
NH2-terminal PH domain makes specific interactions with
ligands in the plasma membrane, and that, despite having
similar structures, other PH domains cannot effectively
substitute in these associations.
PIP2-binding Residues in the NH2-terminal PH Domain 
Are Necessary for Pleckstrin’s Membrane Association
Fesik and co-workers mapped the sites of PIP2 interaction
within the NH2-terminal PH domain of pleckstrin, based
on 31P chemical shifts seen in PIP2 upon addition of the
N2-terminal PH domain (14). A cluster of three lysine resi-
dues (K13, K14, and K22) was shown to be critical in me-
diating the association of pleckstrin’s NH2-terminal PH
domain with PIP2. When any one of these residues was
mutated to an asparagine, the affinity of the resultant mol-
ecule for PIP2 decreased 10-fold (14). Therefore, we gen-
erated a plasmid that directed the expression of a pleck-
strin variant in which the first two of these lysines were
mutated to asparagines (N13, N14) and tested this variant
for its ability to associate with membranes. This pleckstrin
variant also migrated at its predicted molecular weight on
SDS polyacrylamide gels, and in vivo labeling studies dem-
onstrated that its phosphorylation was approximately
equal to that of the wild-type protein when overexpressed
in Cos-1 cells (data not shown). Cells expressing this vari-
ant stained diffusely, had no dorsal projections, and were
not broadened. This finding argues that interactions be-
tween pleckstrin’s NH2-terminal PH domain and PIP2 may
be critical for its association with membranes (Fig. 8).
Pleckstrin Promotes the Formation
of Membrane Projections from the Dorsal Surface
of Transfected Cells
To determine if pleckstrin was inducing the formation of
the dorsal villous projections or was merely being re-
cruited to these membrane structures, we used fluores-
cently labeled WGA, which binds to cell surface glyco-
proteins and thus labels the surfaces of all cells, including
cells not expressing pleckstrin. By fluorescently labeling
the cell surface and then staining for expressed pleckstrin,
we could study whether cells expressing pleckstrin differed
in their surface morphology from those cells not express-
ing pleckstrin. Under these conditions, only cells express-
ing wild-type pleckstrin demonstrated surface projections
(Fig. 9, a and b). This is in contrast to cells transfected with
the pleckstrin variant missing its PH domains and non-
transfected cells, which did not have dorsal projections
(Fig. 9, c and d). This observation is consistent with pleck-
strin actually inducing the formation of these membrane
structures and changing cell surface architecture, in a fash-
ion dependent on the presence of its PH domains.
Discussion
Although the phosphorylation of pleckstrin has long been
used as a marker for platelet activation, we are only now
beginning to understand its intracellular role. Previous
works have suggested that pleckstrin may: (a) inhibit the
hydrolysis of PIP2 by multiple isoforms of PLC (1); (b) in-
hibit the phosphorylation of PIP2 by a Gbg-activated iso-
form of PI3-K (3); and (c) activate an inositol 1,4,5-tris-
phosphate–specific 59 inositol phosphatase (5). These
activities are all regulated by phosphorylation of pleck-
strin near its NH2-terminal PH domain (2, 3, 5). This
present study builds on these findings and shows that
pleckstrin associates with the plasma membrane and pe-
ripheral ruffles by a mechanism dependent on both pleck-
strin phosphorylation and an intact NH2-terminal PH do-
main. In addition, we show that pleckstrin induces the
formation and associates with dorsal membrane projec-
tions in transfected Cos-1 cells. These observations raise a
number of questions, including the specificity of the PH
domains in membrane targeting, the potential membrane-
bound ligands for pleckstrin, and the significance of both
the dorsal projections and pleckstrin’s intracellular local-
ization.
Since PH domains were first reported as components of
signaling molecules other than pleckstrin itself, they have
been proposed as structural motifs important in recruiting
molecules to the plasma membrane. A preponderance of
evidence now exists supporting this hypothesis (22, 25, 31–
33, 41, 45). However, even though the three-dimensional
structures from different PH domains are strikingly similar
in their backbone, there exist regions of marked primary
and tertiary structural diversity (6–8, 11, 27, 37, 46). It
stands to reason that these signaling modules may not be
Figure 8. Effect of mutating PIP2-binding residues in NH2-termi-
nal PH domain. Cos-1 cells were transiently transfected with a
vector encoding the HA-tagged pleckstrin variant K13N, K14N,
and then stained with 12CA5. This variant produced a diffuse
pattern of staining, thus demonstrating that mutating two resi-
dues in pleckstrin’s NH2-terminal PH domain can disrupt the
membrane association of the entire molecule. This suggests a crit-
ical role for interactions between PIP2 and pleckstrin’s NH2-ter-
minal PH domain in mediating recruitment of the molecule to the
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interchangeable between molecules. Consistent with this
proposal, PH domains from different proteins have differ-
ent binding affinities for inositol phosphates (13, 24), Gbg
(28), and brain membranes (41). Our results support the
hypothesis that PH domains have different specificities for
ligands within the membrane by demonstrating that pleck-
strin can be recruited to membrane structures by its own
NH2-terminal PH domain, but not by other PH domains.
The identity of the specific ligands targeted by PH do-
mains remains unresolved. Several classes of molecules
have now been proposed as potential PH domain ligands,
including PIP2, Gbg, and phosphotyrosine residues. The
data showing that pleckstrin is able to inhibit PLCg as well
as PLCb suggest a direct interaction between pleckstrin
and PIP2. However, the observation that pleckstrin is able
to inhibit only the Gbg-activated isoform of PI3-K and not
the isoforms of PI3-K activated by growth factor receptors
suggests that Gbg may as well be able to modulate pleck-
strin’s interaction with other ligands. The data presented
here showing that targeted mutations of PIP2-binding resi-
dues within the NH2-terminal PH domain disrupt pleck-
strin’s membrane association support a role for PIP2 as a
physiologic ligand for pleckstrin and its NH2-terminal PH
domain. Additionally, our preliminary studies in Cos-1 cells
reveal that overexpression of either wild-type or noniso-
prenylated Gbg heterodimers has no effect on pleckstrin’s
membrane localization.
The appearance of expressed pleckstrin within dorsal
projections of transfected cells is intriguing, especially
since pleckstrin variants lacking the NH2-terminal PH do-
main are not seen in these structures. Moreover, we have
shown that pleckstrin, in a fashion dependent on its PH
domains, is in fact inducing the formation of these projec-
tions. Interestingly, the appearance of these projections is
reminiscent of the findings seen in CV-1 cells expressing
the actin-binding protein, villin (9, 10). Since villin also
binds PIP2 (20), it is tempting to speculate that pleckstrin
may be causing the appearance of these villous projections
in a PIP2-dependent manner. Determining whether pleck-
strin is inducing the formation of these structures, and the
other factors that may regulate this process, are areas of
ongoing investigation in our laboratory.
It is striking that the structural regions within pleckstrin
that regulate its ability to inhibit the accumulation of sec-
ond messengers are the same regions that affect its intra-
cellular localization. Both pleckstrin-mediated biochemi-
Figure 9. Effect of pleckstrin variants on cell surface morphology. Cells expressing either HA-tagged pleckstrin or the HA-tagged dou-
ble PH-deleted pleckstrin (D6-99, D246-345) were surface labeled with TRITC-conjugated WGA, and then fixed and stained with
12CA5. Cells expressing HA-tagged wild-type pleckstrin are shown in a and b, and cells expressing the HA-tagged double PH-deleted
pleckstrin variant are shown in c and d. a and c show 12CA5 staining for the HA epitope, and b and d show TRITC-conjugated WGA
staining of the cell surface. Cells expressing wild-type pleckstrin exhibit projections from the dorsal surface of the cell (b), and pleckstrin
is found within these projections (a). In contrast, cells expressing the double PH domain-deleted variant of pleckstrin exhibit diffuse
pleckstrin staining (c) and fail to form dorsal projections (d). This suggests a new role for pleckstrin in mediating morphologic changes
at the cell surface.Ma et al. Pleckstrin and Membranes 1079
cal effects and the recruitment of pleckstrin to peripheral
membranes require pleckstrin phosphorylation and an in-
tact NH2-terminal PH domain. Control of the intracellular
location of signaling molecules is a common method of
regulating their function. An attractive hypothesis is that
pleckstrin is recruited to the peripheral membrane upon
cell activation by potential ligands such as PIP2 or Gbg. We
are actively investigating whether pleckstrin’s activity is
regulated by localization to the proximity of these biochemi-
cal targets.
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